Lexeo Therapeutics, Inc. (LXEO) Research & Development (2022 - 2023)
Lexeo Therapeutics' Research & Development history spans 2 years, with the latest figure at $8.2 million for Q4 2023.
- For Q4 2023, Research & Development fell 27.9% year-over-year to $8.2 million; the TTM value through Dec 2023 reached $53.1 million, changed N/A, while the annual FY2024 figure was $74.1 million, 39.45% up from the prior year.
- Research & Development for Q4 2023 was $8.2 million at Lexeo Therapeutics, down from $17.2 million in the prior quarter.
- Across five years, Research & Development topped out at $17.2 million in Q3 2023 and bottomed at $8.2 million in Q4 2023.